Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
lilotomab (4 trials)
rituximab (rituxan) (1 trial)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 1)
Lymphoma, Follicular (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Lymphoma, Non-Hodgkin (Phase 2)
Trials (4 total)
Trial APIs (2 total)